# Analysis of Volatile Organic Compounds in Exhaled Air and Sweat: Interest in Rapid Screening for COVID-19 Infection.

> **NCT04817371** · NA · UNKNOWN · sponsor: **Hopital Foch** · enrollment: 192 (estimated)

## Conditions studied

- Covid19

## Interventions

- **DEVICE:** Volatile Organic Compounds analysis (e-noses)
- **OTHER:** Canine odor detection of Volatile Organic Compounds
- **DEVICE:** Volatile Organic Compounds analysis (mass spectrometry)
- **DEVICE:** Volatile Organic Compounds analysis in sweat (mass spectrometry)

## Key facts

- **NCT ID:** NCT04817371
- **Lead sponsor:** Hopital Foch
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-03-01
- **Primary completion:** 2022-09
- **Final completion:** 2022-09
- **Target enrollment:** 192 (ESTIMATED)
- **Last updated:** 2022-08-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04817371

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04817371, "Analysis of Volatile Organic Compounds in Exhaled Air and Sweat: Interest in Rapid Screening for COVID-19 Infection.". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT04817371. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*